0 XP   0   0   0

FDC Limited
Buy, Hold or Sell?

Should you buy, hold or sell FDC Limited?

I guess you are interested in FDC Limited. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

Let's analyse FDC Limited

Let's start. I'm going to help you getting a better view of FDC Limited. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

  1. Company's Financial Health
    A deep dive into the books. How are the numbers doing? Is FDC Limited even making a profit? Is the company skyrocketing? Or is it sinking like the Titanic. The trend is your friend.
  2. Market Valuation
    Finally, you now have an insight of how FDC Limited is doing in the market. If the company is worth buying. The latest step is to find out how other investors value FDC Limited. The closing price on 2023-02-08 was INR262.95 per share. Is the company over- or underpriced?
  3. Key Performance Indicators
    A total overlook on how the company is doing. Based on the (trends in) the key performance indicators.
FDC Limited Daily Candlestick Chart
FDC Limited Daily Candlestick Chart
Summary









1. Valuation of FDC Limited




Current price per share

INR262.95

2. Growth of FDC Limited




Is FDC Limited growing?

Current yearPrevious yearGrowGrow %
How rich?$236.7m$209.8m$26.9m11.4%

How much money is FDC Limited making?

Current yearPrevious yearGrowGrow %
Making money$26.1m$36.4m-$10.2m-39.3%
Net Profit Margin14.2%22.6%--

How much money comes from the company's main activities?

3. Financial Health of FDC Limited




Comparing to competitors in the Drug Manufacturers - Major industry




  Industry Rankings (Drug Manufacturers - Major)  



Summary

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is efficient in making profit.
Using its investors money, the company is less efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is very efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

1.1. Profitability of FDC Limited.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit FDC Limited earns for each ₹1 of revenue.

  • Above 10% is considered healthy but always compare FDC Limited to the Drug Manufacturers - Major industry mean.
  • A Net Profit Margin of 14.2% means that ₹0.14 for each ₹1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of FDC Limited:

  • The MRQ is 14.2%. The company is making a huge profit. +2
  • The TTM is 14.2%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ14.2%TTM14.2%0.0%
TTM14.2%YOY22.6%-8.4%
TTM14.2%5Y17.2%-3.1%
5Y17.2%10Y17.0%+0.2%
Compared to industry (Drug Manufacturers - Major)
PeriodCompanyIndustry (mean)+/- 
MRQ14.2%10.8%+3.4%
TTM14.2%10.8%+3.4%
YOY22.6%14.8%+7.8%
5Y17.2%12.2%+5.0%
10Y17.0%11.9%+5.1%
1.1.2. Return on Assets

Shows how efficient FDC Limited is using its assets to generate profit.

  • Above 5% is considered healthy but always compare FDC Limited to the Drug Manufacturers - Major industry mean.
  • 9.5% Return on Assets means that FDC Limited generated ₹0.10 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of FDC Limited:

  • The MRQ is 9.5%. Using its assets, the company is efficient in making profit. +1
  • The TTM is 9.5%. Using its assets, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ9.5%TTM9.5%0.0%
TTM9.5%YOY15.4%-5.9%
TTM9.5%5Y12.0%-2.5%
5Y12.0%10Y12.4%-0.4%
Compared to industry (Drug Manufacturers - Major)
PeriodCompanyIndustry (mean)+/- 
MRQ9.5%1.8%+7.7%
TTM9.5%2.3%+7.2%
YOY15.4%3.0%+12.4%
5Y12.0%3.0%+9.0%
10Y12.4%2.7%+9.7%
1.1.3. Return on Equity

Shows how efficient FDC Limited is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare FDC Limited to the Drug Manufacturers - Major industry mean.
  • 11.1% Return on Equity means FDC Limited generated ₹0.11 for each ₹1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of FDC Limited:

  • The MRQ is 11.1%. Using its investors money, the company is less efficient in making profit.
  • The TTM is 11.1%. Using its investors money, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ11.1%TTM11.1%0.0%
TTM11.1%YOY17.4%-6.3%
TTM11.1%5Y13.9%-2.8%
5Y13.9%10Y14.6%-0.8%
Compared to industry (Drug Manufacturers - Major)
PeriodCompanyIndustry (mean)+/- 
MRQ11.1%2.5%+8.6%
TTM11.1%3.9%+7.2%
YOY17.4%4.4%+13.0%
5Y13.9%4.2%+9.7%
10Y14.6%4.0%+10.6%

1.2. Operating Efficiency of FDC Limited.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient FDC Limited is operating .

  • Measures how much profit FDC Limited makes for each ₹1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare FDC Limited to the Drug Manufacturers - Major industry mean.
  • An Operating Margin of 0.0% means the company generated ₹0.00  for each ₹1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of FDC Limited:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y15.4%-15.4%
5Y15.4%10Y17.3%-1.9%
Compared to industry (Drug Manufacturers - Major)
PeriodCompanyIndustry (mean)+/- 
MRQ-29.7%-29.7%
TTM-11.5%-11.5%
YOY-11.7%-11.7%
5Y15.4%12.0%+3.4%
10Y17.3%11.0%+6.3%
1.2.2. Operating Ratio

Measures how efficient FDC Limited is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Major industry mean).
  • An Operation Ratio of 0.39 means that the operating costs are ₹0.39 for each ₹1 in net sales.

Let's take a look of the Operating Ratio trends of FDC Limited:

  • The MRQ is 0.393. The company is very efficient in keeping operating costs low. +2
  • The TTM is 0.393. The company is very efficient in keeping operating costs low. +2
Trends
Current periodCompared to+/- 
MRQ0.393TTM0.3930.000
TTM0.393YOY0.351+0.042
TTM0.3935Y0.849-0.456
5Y0.84910Y1.007-0.158
Compared to industry (Drug Manufacturers - Major)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3930.475-0.082
TTM0.3930.425-0.032
YOY0.3510.731-0.380
5Y0.8490.943-0.094
10Y1.0070.983+0.024

1.3. Liquidity of FDC Limited.

1.3. Liquidity
1.3.1. Current Ratio

Measures if FDC Limited is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Major industry mean).
  • A Current Ratio of 3.68 means the company has ₹3.68 in assets for each ₹1 in short-term debts.

Let's take a look of the Current Ratio trends of FDC Limited:

  • The MRQ is 3.675. The company is very able to pay all its short-term debts. +2
  • The TTM is 3.675. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ3.675TTM3.6750.000
TTM3.675YOY4.577-0.902
TTM3.6755Y3.913-0.238
5Y3.91310Y3.532+0.380
Compared to industry (Drug Manufacturers - Major)
PeriodCompanyIndustry (mean)+/- 
MRQ3.6751.824+1.851
TTM3.6751.800+1.875
YOY4.5771.807+2.770
5Y3.9131.305+2.608
10Y3.5321.218+2.314
1.3.2. Quick Ratio

Measures if FDC Limited is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare FDC Limited to the Drug Manufacturers - Major industry mean.
  • A Quick Ratio of 4.13 means the company can pay off ₹4.13 for each ₹1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of FDC Limited:

  • The MRQ is 4.126. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 4.126. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ4.126TTM4.1260.000
TTM4.126YOY5.835-1.709
TTM4.1265Y4.826-0.700
5Y4.82610Y3.918+0.908
Compared to industry (Drug Manufacturers - Major)
PeriodCompanyIndustry (mean)+/- 
MRQ4.1261.248+2.878
TTM4.1261.200+2.926
YOY5.8351.151+4.684
5Y4.8260.836+3.990
10Y3.9180.750+3.168

1.4. Solvency of FDC Limited.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of FDC Limited assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare FDC Limited to Drug Manufacturers - Major industry mean.
  • A Debt to Asset Ratio of 0.14 means that FDC Limited assets are financed with 13.8% credit (debt) and the remaining percentage (100% - 13.8%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of FDC Limited:

  • The MRQ is 0.138. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.138. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.138TTM0.1380.000
TTM0.138YOY0.114+0.025
TTM0.1385Y0.134+0.004
5Y0.13410Y0.148-0.015
Compared to industry (Drug Manufacturers - Major)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1380.415-0.277
TTM0.1380.419-0.281
YOY0.1140.429-0.315
5Y0.1340.455-0.321
10Y0.1480.431-0.283
1.4.2. Debt to Equity Ratio

Measures if FDC Limited is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare FDC Limited to the Drug Manufacturers - Major industry mean.
  • A Debt to Equity ratio of 16.0% means that company has ₹0.16 debt for each ₹1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of FDC Limited:

  • The MRQ is 0.160. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.160. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.160TTM0.1600.000
TTM0.160YOY0.128+0.032
TTM0.1605Y0.155+0.005
5Y0.15510Y0.175-0.021
Compared to industry (Drug Manufacturers - Major)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1600.675-0.515
TTM0.1600.698-0.538
YOY0.1280.738-0.610
5Y0.1550.840-0.685
10Y0.1750.814-0.639

2. Market Valuation of FDC Limited

2. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₹1 in earnings FDC Limited generates.

  • Above 15 is considered overpriced but always compare FDC Limited to the Drug Manufacturers - Major industry mean.
  • A PE ratio of 20.04 means the investor is paying ₹20.04 for every ₹1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of FDC Limited:

  • The EOD is 20.512. Very good. +2
  • The MRQ is 20.040. Very good. +2
  • The TTM is 20.040. Very good. +2
Trends
Current periodCompared to+/- 
EOD20.512MRQ20.040+0.472
MRQ20.040TTM20.0400.000
TTM20.040YOY16.005+4.035
TTM20.0405Y18.504+1.536
5Y18.50410Y18.145+0.359
Compared to industry (Drug Manufacturers - Major)
PeriodCompanyIndustry (mean)+/- 
EOD20.51273.229-52.717
MRQ20.04066.328-46.288
TTM20.04060.797-40.757
YOY16.00533.289-17.284
5Y18.50460.412-41.908
10Y18.14564.422-46.277
2.2. Price Earnings to Growth Ratio

Measures the predicted future growth of FDC Limited.

  • Lower is better.
  • A PEG ratio of 1 means the market price of the stock and the expected future earnings are on par.

Let's take a look of the Price Earnings to Growth Ratio trends of FDC Limited:

  • The MRQ is 27.906. Seems overpriced? -1
  • The TTM is 27.906. Seems overpriced? -1
Trends
Current periodCompared to+/- 
MRQ27.906TTM27.9060.000
TTM27.906YOY12.579+15.327
TTM27.9065Y18.945+8.961
5Y18.94510Y18.117+0.828
Compared to industry (Drug Manufacturers - Major)
PeriodCompanyIndustry (mean)+/- 
MRQ27.906-0.235+28.141
TTM27.9060.137+27.769
YOY12.5790.124+12.455
5Y18.9450.232+18.713
10Y18.1170.222+17.895

2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of FDC Limited is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Drug Manufacturers - Major industry mean).
  • A PB ratio of 2.22 means the investor is paying ₹2.22 for each ₹1 in book value.

Let's take a look of the Price to Book Ratio trends of FDC Limited:

  • The EOD is 2.268. Good. +1
  • The MRQ is 2.216. Good. +1
  • The TTM is 2.216. Good. +1
Trends
Current periodCompared to+/- 
EOD2.268MRQ2.216+0.052
MRQ2.216TTM2.2160.000
TTM2.216YOY2.781-0.565
TTM2.2165Y2.525-0.309
5Y2.52510Y2.624-0.100
Compared to industry (Drug Manufacturers - Major)
PeriodCompanyIndustry (mean)+/- 
EOD2.2681.495+0.773
MRQ2.2161.439+0.777
TTM2.2161.890+0.326
YOY2.7812.460+0.321
5Y2.5251.972+0.553
10Y2.6242.221+0.403
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of FDC Limited compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--13.19013.1900%12.220+8%8.898+48%12.880+2%
Book Value Growth--1.1281.1280%1.121+1%1.091+3%1.112+1%
Book Value Per Share--115.917115.9170%102.727+13%93.038+25%78.476+48%
Book Value Per Share Growth--1.1281.1280%1.135-1%1.103+2%1.111+2%
Current Ratio--3.6753.6750%4.577-20%3.913-6%3.532+4%
Debt To Asset Ratio--0.1380.1380%0.114+22%0.134+3%0.148-7%
Debt To Equity Ratio--0.1600.1600%0.128+25%0.155+3%0.175-9%
Dividend Per Share----0%-0%0.713-100%1.557-100%
Eps--12.81912.8190%17.851-28%12.8770%11.308+13%
Eps Growth--0.7180.7180%1.272-44%1.070-33%1.080-34%
Free Cash Flow Per Share--1.7241.7240%8.562-80%6.714-74%4.138-58%
Free Cash Flow Per Share Growth--0.2010.2010%0.668-70%1.118-82%7.653-97%
Free Cash Flow To Equity Per Share--1.1421.1420%0.900+27%1.460-22%-0.226+120%
Free Cash Flow To Equity Per Share Growth--1.2681.2680%0.199+536%1.076+18%0.249+409%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--1.172--------
Intrinsic Value_10Y_min--1.532--------
Intrinsic Value_1Y_max--1.381--------
Intrinsic Value_1Y_min--1.342--------
Intrinsic Value_3Y_max--3.186--------
Intrinsic Value_3Y_min--3.026--------
Intrinsic Value_5Y_max--3.831--------
Intrinsic Value_5Y_min--3.596--------
Net Profit Margin--0.1420.1420%0.226-37%0.172-18%0.170-17%
Operating Margin----0%-0%0.154-100%0.173-100%
Operating Ratio--0.3930.3930%0.351+12%0.849-54%1.007-61%
Pb Ratio2.268+2%2.2162.2160%2.781-20%2.525-12%2.624-16%
Pe Ratio20.512+2%20.04020.0400%16.005+25%18.504+8%18.145+10%
Peg Ratio--27.90627.9060%12.579+122%18.945+47%18.117+54%
Price Per Share262.950+2%256.900256.9000%285.700-10%231.560+11%202.750+27%
Price To Total Gains Ratio19.936+2%19.47719.4770%23.380-17%27.845-30%22.445-13%
Profit Growth--0.7180.7180%1.256-43%1.057-32%1.080-33%
Quick Ratio--4.1264.1260%5.835-29%4.826-15%3.918+5%
Return On Assets--0.0950.0950%0.154-38%0.120-21%0.124-23%
Return On Equity--0.1110.1110%0.174-36%0.139-20%0.146-24%
Revenue Growth--1.1461.1460%0.992+16%1.082+6%1.080+6%
Total Gains Per Share--13.19013.1900%12.220+8%9.611+37%14.436-9%
Total Gains Per Share Growth--1.0791.0790%1.448-25%1.233-12%1.0840%
Usd Book Value--236771638.400236771638.4000%209830322.900+13%192624766.620+23%162597665.022+46%
Usd Book Value Change Per Share--0.1600.1600%0.148+8%0.108+48%0.156+2%
Usd Book Value Per Share--1.4031.4030%1.243+13%1.126+25%0.950+48%
Usd Dividend Per Share----0%-0%0.009-100%0.019-100%
Usd Eps--0.1550.1550%0.216-28%0.1560%0.137+13%
Usd Free Cash Flow----0%-0%-0%-0%
Usd Free Cash Flow Per Share--0.0210.0210%0.104-80%0.081-74%0.050-58%
Usd Free Cash Flow To Equity Per Share--0.0140.0140%0.011+27%0.018-22%-0.003+120%
Usd Price Per Share3.182+2%3.1083.1080%3.457-10%2.802+11%2.453+27%
Usd Profit--26184799.30026184799.3000%36462817.600-28%26642389.840-2%23414746.300+12%
Usd Revenue--184878259.500184878259.5000%161317611.400+15%154374154.660+20%136899972.733+35%
Usd Total Gains Per Share--0.1600.1600%0.148+8%0.116+37%0.175-9%
 EOD+2 -3MRQTTM+0 -0YOY+15 -225Y+15 -2510Y+22 -18

3.2. Fundamental Score

Let's check the fundamental score of FDC Limited based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1520.512
Price to Book Ratio (EOD)Between0-12.268
Net Profit Margin (MRQ)Greater than00.142
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than14.126
Current Ratio (MRQ)Greater than13.675
Debt to Asset Ratio (MRQ)Less than10.138
Debt to Equity Ratio (MRQ)Less than10.160
Return on Equity (MRQ)Greater than0.150.111
Return on Assets (MRQ)Greater than0.050.095
Total6/10 (60.0%)

3.3. Technical Score

Let's check the technical score of FDC Limited based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose260.000
Total0/1 (0.0%)



Latest Balance Sheet

Balance Sheet of 2022-03-31. Currency in INR. All numbers in thousands.

Summary
Total Assets22,702,044
Total Liabilities3,134,140
Total Stockholder Equity19,567,904
 As reported
Total Liabilities 3,134,140
Total Stockholder Equity+ 19,567,904
Total Assets = 22,702,044

Assets

Total Assets22,702,044
Total Current Assets10,001,877
Long-term Assets10,001,877
Total Current Assets
Cash And Cash Equivalents 313,753
Short-term Investments 5,016,652
Net Receivables 819,175
Inventory 3,285,031
Other Current Assets 381,199
Total Current Assets  (as reported)10,001,877
Total Current Assets  (calculated)9,815,810
+/- 186,067
Long-term Assets
Property Plant Equipment 8,052,481
Intangible Assets 46,326
Long-term Assets  (as reported)0
Long-term Assets  (calculated)8,098,807
+/- 8,098,807

Liabilities & Shareholders' Equity

Total Current Liabilities2,721,553
Long-term Liabilities-
Total Stockholder Equity19,567,904
Total Current Liabilities
Total Current Liabilities  (as reported)2,721,553
Total Current Liabilities  (calculated)0
+/- 2,721,553
Long-term Liabilities
Long term Debt Total 252,811
Long-term Liabilities  (as reported)0
Long-term Liabilities  (calculated)252,811
+/- 252,811
Total Stockholder Equity
Common Stock168,810
Retained Earnings 19,299,790
Other Stockholders Equity 99,304
Total Stockholder Equity (as reported)19,567,904
Total Stockholder Equity (calculated)19,567,904
+/-0
Other
Cash And Equivalents63,500
Cash and Short Term Investments 5,393,905
Common Stock Shares Outstanding 168,810
Liabilities and Stockholders Equity 22,702,044



Balance Sheet

Currency in INR. All numbers in thousands.

 Trend2022-03-312021-03-312020-03-312019-03-312018-03-312017-03-312016-03-312015-03-312014-03-31
> Total Assets 
10,591,801
11,486,769
12,658,187
14,679,374
15,052,124
16,398,846
18,129,291
19,562,332
22,702,044
22,702,04419,562,33218,129,29116,398,84615,052,12414,679,37412,658,18711,486,76910,591,801
   > Total Current Assets 
4,389,571
5,021,273
5,233,629
7,082,564
7,223,268
7,399,985
9,271,308
9,337,497
10,001,877
10,001,8779,337,4979,271,3087,399,9857,223,2687,082,5645,233,6295,021,2734,389,571
       Cash And Cash Equivalents 
234,258
149,458
180,179
284,276
123,000
36,628
7,742
304,315
313,753
313,753304,3157,74236,628123,000284,276180,179149,458234,258
       Short-term Investments 
2,299,045
2,724,889
0
4,365,270
3,971,575
4,059,277
5,022,412
5,248,406
5,016,652
5,016,6525,248,4065,022,4124,059,2773,971,5754,365,27002,724,8892,299,045
       Net Receivables 
654,731
746,379
616,784
758,051
814,076
872,729
1,234,827
1,102,801
819,175
819,1751,102,8011,234,827872,729814,076758,051616,784746,379654,731
       Inventory 
1,030,022
1,232,180
1,309,081
1,438,087
1,679,299
1,802,858
2,195,947
2,262,658
3,285,031
3,285,0312,262,6582,195,9471,802,8581,679,2991,438,0871,309,0811,232,1801,030,022
       Other Current Assets 
133,287
132,006
196,151
117,814
332,828
345,535
239,536
249,169
381,199
381,199249,169239,536345,535332,828117,814196,151132,006133,287
   > Long-term Assets 
0
0
0
7,490,587
7,828,856
8,998,861
8,857,983
0
0
008,857,9838,998,8617,828,8567,490,587000
       Property Plant Equipment 
2,996,732
4,195,660
6,911,872
6,745,490
6,784,011
6,881,284
6,911,335
7,039,683
8,052,481
8,052,4817,039,6836,911,3356,881,2846,784,0116,745,4906,911,8724,195,6602,996,732
       Long Term Investments 
1,869,223
2,167,203
394,300
544,860
0
0
0
0
0
00000544,860394,3002,167,2031,869,223
       Intangible Assets 
28,290
22,795
38,965
98,264
80,867
64,383
62,195
43,948
46,326
46,32643,94862,19564,38380,86798,26438,96522,79528,290
> Total Liabilities 
2,138,832
2,122,998
1,833,499
1,977,401
2,291,022
1,946,486
2,654,995
2,220,983
3,134,140
3,134,1402,220,9832,654,9951,946,4862,291,0221,977,4011,833,4992,122,9982,138,832
   > Total Current Liabilities 
1,826,232
1,879,681
1,634,222
1,793,156
2,114,544
1,790,575
2,463,387
2,039,991
2,721,553
2,721,5532,039,9912,463,3871,790,5752,114,5441,793,1561,634,2221,879,6811,826,232
       Short-term Debt 
26,294
20,658
8,979
7,863
0
0
0
3,934
0
03,9340007,8638,97920,65826,294
       Short Long Term Debt 
26,294
20,658
8,979
7,863
903
1,144
1,465
0
0
001,4651,1449037,8638,97920,65826,294
       Accounts payable 
800,546
871,723
825,934
778,748
973,186
776,139
1,178,573
0
0
001,178,573776,139973,186778,748825,934871,723800,546
       Other Current Liabilities 
772,629
751,800
408,118
437,957
579,260
544,553
625,641
0
0
00625,641544,553579,260437,957408,118751,800772,629
   > Long-term Liabilities 
0
0
0
184,245
176,478
155,911
191,608
0
0
00191,608155,911176,478184,245000
       Long term Debt Total 
0
0
7,863
6,948
6,045
4,901
96,305
70,036
252,811
252,81170,03696,3054,9016,0456,9487,86300
       Capital Lease Obligations 
0
0
0
0
0
0
145,866
0
0
00145,866000000
       Deferred Long Term Liability 
4,685
4,293
0
0
0
0
0
0
0
00000004,2934,685
> Total Stockholder Equity
8,452,969
9,363,771
10,824,688
12,701,973
12,761,102
14,452,360
15,474,296
17,341,349
19,567,904
19,567,90417,341,34915,474,29614,452,36012,761,10212,701,97310,824,6889,363,7718,452,969
   Common Stock
177,833
177,833
178,619
178,619
175,189
175,189
170,973
168,810
168,810
168,810168,810170,973175,189175,189178,619178,619177,833177,833
   Retained Earnings 
8,228,980
9,142,308
10,627,172
12,510,566
12,557,600
14,251,615
15,282,795
17,124,473
19,299,790
19,299,79017,124,47315,282,79514,251,61512,557,60012,510,56610,627,1729,142,3088,228,980
   Capital Surplus 
0
0
7,290
7,290
0
0
0
0
0
000007,2907,29000
   Treasury Stock000000000
   Other Stockholders Equity 
38,866
36,340
11,607
5,498
28,313
25,556
20,528
48,066
99,304
99,30448,06620,52825,55628,3135,49811,60736,34038,866



Balance Sheet

Currency in INR. All numbers in thousands.




Cash Flow

Currency in INR. All numbers in thousands.




Income Statement

Currency in INR. All numbers in thousands.


Latest Income Statement (annual, 2022-03-31)

Gross Profit (+$)
totalRevenue15,279,195
Cost of Revenue-6,004,563
Gross Profit9,274,6329,274,632
 
Operating Income (+$)
Gross Profit9,274,632
Operating Expense--
Operating Income2,163,8479,274,632
 
Operating Expense (+$)
Research Development-
Selling General Administrative6,426,897
Selling And Marketing Expenses-
Operating Expense-6,426,897
 
Net Interest Income (+$)
Interest Income654,245
Interest Expense--
Net Interest Income-654,245
 
Pretax Income (+$)
Operating Income2,163,847
Net Interest Income-
Other Non-Operating Income Expenses-
Income Before Tax (EBT)2,893,9012,163,847
EBIT - interestExpense = 0
2,164,033
2,164,033
Interest Expense-
Earnings Before Interest and Taxes (ebit)-2,893,901
Earnings Before Interest and Taxes (ebitda)-
 
After tax Income (+$)
Income Before Tax2,893,901
Tax Provision-732,252
Net Income From Continuing Ops-2,161,649
Net Income2,164,033
Net Income Applicable To Common Shares2,164,033
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-0
 

Comments

Join the conversation.

Leave a comment

Stay informed with my latest content.

Subscribe to my newsletter and receive an email as soon as I add content to PenkeTrading.com.


By clicking Register, you agree to the General Terms and Conditions.
Penke's Market Notifications
PWASML.BSE
2 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of PWASML.BSE.

PWASML.BSE Daily Candlestick Chart
PSB.NSE
4 minutes ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of PSB.NSE.

PSB.NSE Daily Candlestick Chart
PRIVISCL.BSE
4 minutes ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of PRIVISCL.BSE.

PRIVISCL.BSE Daily Candlestick Chart
PRIVISCL.NSE
5 minutes ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of PRIVISCL.NSE.

PRIVISCL.NSE Daily Candlestick Chart
PRINCEPIPE.NSE
6 minutes ago

I found you a Golden Cross on the daily chart of PRINCEPIPE.NSE.

PRINCEPIPE.NSE Daily Candlestick Chart
JIHD.JK
8 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of JIHD.JK.

JIHD.JK Daily Candlestick Chart
INCI.JK
14 minutes ago

I found you a Death Cross on the daily chart of INCI.JK.

INCI.JK Daily Candlestick Chart
IMAS.JK
14 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of IMAS.JK.

IMAS.JK Daily Candlestick Chart
FIRE.JK
22 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of FIRE.JK.

FIRE.JK Daily Candlestick Chart
PGFOILQ.BSE
22 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of PGFOILQ.BSE.

PGFOILQ.BSE Daily Candlestick Chart
APII.JK
34 minutes ago

I found you a Death Cross on the daily chart of APII.JK.

APII.JK Daily Candlestick Chart
AIMS.JK
36 minutes ago

I found you a Golden Cross on the daily chart of AIMS.JK.

AIMS.JK Daily Candlestick Chart
ADMF.JK
37 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of ADMF.JK.

ADMF.JK Daily Candlestick Chart
NIACL.BSE
52 minutes ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of NIACL.BSE.

NIACL.BSE Daily Candlestick Chart
NIACL.NSE
53 minutes ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of NIACL.NSE.

NIACL.NSE Daily Candlestick Chart
NGIL.BSE
53 minutes ago

I found you a STOCH Bearish Hidden Divergence on the daily chart of NGIL.BSE.

NGIL.BSE Daily Candlestick Chart
VAVA.XETRA
1 hour ago

I found you a STOCH Bullish Hidden Divergence on the daily chart of VAVA.XETRA.

VAVA.XETRA Daily Candlestick Chart
O39.SG
1 hour ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of O39.SG.

O39.SG Daily Candlestick Chart
M44U.SG
1 hour ago

I found you a Golden Cross on the daily chart of M44U.SG.

M44U.SG Daily Candlestick Chart
F9D.SG
1 hour ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of F9D.SG.

F9D.SG Daily Candlestick Chart
A7RU.SG
1 hour ago

I found you a Golden Cross on the daily chart of A7RU.SG.

A7RU.SG Daily Candlestick Chart
CHJ.SG
1 hour ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of CHJ.SG.

CHJ.SG Daily Candlestick Chart
PSE.VN
1 hour ago

I found you a STOCH Bearish Reversal Divergence on the daily chart of PSE.VN.

PSE.VN Daily Candlestick Chart
QTXB.PINK
1 hour ago

I found you a MACD Bearish Reversal Divergence on the daily chart of QTXB.PINK.

QTXB.PINK Daily Candlestick Chart